Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Reus

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 23, 2024
Social dysfunction relates to shifts within socioaffective brain systems among Schizophrenia and Alzheimer's disease patientsSimon Braak, Brenda Wjh Penninx, Tanja Su, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2024
Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3Daniel J Panyard, Lianne M Reus, Muhammad Ali, et al.
Nature Aging|January 9, 2024
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profilesBetty M Tijms, Ellen M Vromen, Olav Mjaavatten, et al.
Brain Communications|July 11, 2025
Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Lianne M Reus, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2022
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Betty Tijms, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Annals of Neurology|April 11, 2025
UNC13A Polymorphism Influences Survival in Patients with Frontotemporal DementiaLianne M Reus, Sean W Willemse, Sterre C M de Boer, et al.
European Heart Journal|March 12, 2019
Associations between vascular risk factors and brain MRI indices in UK BiobankSimon R Cox, Donald M Lyall, Stuart J Ritchie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2024
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's diseaseAurore Delvenne, Johan Gobom, Suzanne E Schindler, et al.
International Review of Psychiatry (Abingdon, England)|December 24, 2025
Polygenic risk for psychiatric disorders and its association with neuropsychiatric symptoms in dementiaJenna Najar, Itziar de Rojas, Maria Carolina Dalmasso, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 23, 2024
Social dysfunction relates to shifts within socioaffective brain systems among Schizophrenia and Alzheimer's disease patientsSimon Braak, Brenda Wjh Penninx, Tanja Su, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2024
Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3Daniel J Panyard, Lianne M Reus, Muhammad Ali, et al.
Nature Aging|January 9, 2024
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profilesBetty M Tijms, Ellen M Vromen, Olav Mjaavatten, et al.
Brain Communications|July 11, 2025
Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Lianne M Reus, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2022
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Betty Tijms, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Annals of Neurology|April 11, 2025
UNC13A Polymorphism Influences Survival in Patients with Frontotemporal DementiaLianne M Reus, Sean W Willemse, Sterre C M de Boer, et al.
European Heart Journal|March 12, 2019
Associations between vascular risk factors and brain MRI indices in UK BiobankSimon R Cox, Donald M Lyall, Stuart J Ritchie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2024
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's diseaseAurore Delvenne, Johan Gobom, Suzanne E Schindler, et al.
International Review of Psychiatry (Abingdon, England)|December 24, 2025
Polygenic risk for psychiatric disorders and its association with neuropsychiatric symptoms in dementiaJenna Najar, Itziar de Rojas, Maria Carolina Dalmasso, et al.
Pageof 8